The largest database of trusted experimental protocols

Jcsg plus screen

Manufactured by Molecular Dimensions

The JCSG-plus screen is a crystallization screening kit designed to facilitate the identification of initial crystallization conditions for proteins. It contains a diverse set of chemical conditions that have been shown to be effective in producing protein crystals. The screen is intended to provide a starting point for optimization of crystallization conditions.

Automatically generated - may contain errors

8 protocols using jcsg plus screen

1

Optimizing Crystallization of sAD/GP1MACV Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Screening for initial crystallization conditions was done with an 8.8 mg/ml stock of the complex sAD/GP1MACV, using a Mosquito crystallization robot (TTP Labs). Initial hits were identified using the JCSG-plus screen (Molecular Dimensions) and were optimized manually. Crystals were obtained using sitting drop vapor diffusion in 0.2 M sodium thiocyanate, pH 6.9, 20% (w/v) PEG 3350, and 5% (v/v) MPD. Crystals were then successively cryo-protected using 20% (v/v) MPD in reservoir solution before flash cooling in liquid nitrogen.
+ Open protocol
+ Expand
2

Optimizing Protein Crystal Growth Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
An initial hit was also identified in well A5 of the JCSG-plus screen from Molecular Dimensions (Newman et al., 2005 ▸ ) with conditions consisting of 0.2 M magnesium formate, 20%(w/v) PEG 3350. Optimization of the magnesium formate, PEG 3350 and protein concentrations resulted in larger crystals with the same morphology. The final optimized conditions were 0.6 µl GBA (10 mg ml−1) plus 0.5 µl well solution [0.2 M magnesium formate, 19%(v/v) PEG 3350].
+ Open protocol
+ Expand
3

Protein crystal growth by vapor diffusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Crystals were obtained by sitting-drop vapour diffusion using the commercial JCSG-plus screen (Molecular Dimensions) in a 96-well format and using a liquid-handling robot (Mosquito, TTP Labtech) to pipet drops of 150 nl protein solution plus 150 nl reservoir solution. Diffraction-quality crystals appeared over a reservoir consisting of 0.2 M ammonium citrate dibasic, 20%(w/v) polyethylene glycol 3350. In preparation for X-ray diffraction experiments, crystals were immersed for a few seconds in reservoir solution supplemented with 10%(v/v) ethylene glycol, mounted in nylon loops and quenched in liquid nitrogen.
+ Open protocol
+ Expand
4

Fluorescent Protein Crystallization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each protein was trace fluorescently labeled (TFL) as described previously (Pusey et al., 2015 ▸ ) using either Cascade Yellow (CY; Invitrogen, catalog No. C-10164), Carboxy­rhodamine 6G (CR; Invitrogen, catalog No. C-6157) or Pacific Blue (PB; Invitrogen, catalog No. P-10163). Crystallization plates were set up using (i) CY-labeled ConA, (ii) CR-labeled ConA, (iii) PB-labeled ConA, (iv) a mixture containing 50% PB-labeled ConA and 50% CR-labeled ConA, (v) CR-labeled β-lactoglobulin B and (vi) CY-labeled trypsin. The sitting-drop vapor-diffusion method was used for all crystallizations. ConA was crystallized using the JCSG-plus screen (Molecular Dimensions, catalog No. MD1-37) in Corning CrystalEX plates (Hampton Research, catalog No. HR8-140). Each of the 96 reservoirs was filled with 50 ml precipitant solution, and the three wells were prepared at protein:precipitant ratios of 1:1, 2:1 and 1:2. All plates were stored at room temperature. Trypsin was crystallized using the conditions given on the Rigaku website (http://www.rigaku.com) and β-lactoglobulin B was crystallized from 0.1 M sodium citrate, 3.0 M ammonium sulfate pH 4.0.
+ Open protocol
+ Expand
5

Optimized Crystallization Conditions for CBSΔ409–551 p.P49L

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initial crystallization screenings for CBSΔ409–551 p.P49L were performed in 96-well plates at 293 K using a Cartesian mini-Bee nanoliter-drop dispensing robot (Genomic Solutions). These screenings allowed for the identification of one hit for CBSΔ409–551 p.P49L from the JCSGplus™ screen (Molecular Dimensions): G10 (0.15 M KBr, 30% w/v PEG 2000 MME). Crystals were optimized at the microliter scale using sitting-drop vapor diffusion with a drop composition of 0.5 µl protein solution (27.4 mg·ml−1 in buffer A with 20 µM PLP) and 0.5 µl reservoir solution (0.15 M NaBr, 35% PEG 2000 MME) equilibrated against 500 µl precipitant solution in the well. Dark orange colored small needles as well as big rod-shaped crystals appeared after 12 h at 20°C.
+ Open protocol
+ Expand
6

Crystallization Protocol for MmGADL1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initial crystallization conditions for MmGADL1 were obtained from the JCSG-plus screen (Molecular Dimensions) using sitting-drop vapour diffusion. The crystallization conditions, which yielded crystals with a needle morphology arranged as single crystals or point-originated clusters, were comprised of 80 mM sodium cacodylate pH 6.0–7.4, 13–14%(w/v) PEG 8000, 120–160 mM calcium acetate, 15.0–17.5%(w/v) glycerol. 0.3–1.5 µl drops with different volume ratios of protein solution (6.5–7.5 mg ml−1 in 20 mM HEPES pH 7.4, 200 mM NaCl) and reservoir solution were used at 281 and 293 K, equilibrating against 40 µl reservoir solution. Crystals were briefly soaked in cryoprotectant solutions and flash-cooled in liquid N2. The detailed conditions used to obtain the crystals used for data collection are given in Table 1.
+ Open protocol
+ Expand
7

Optimizing DYRK1A Kinase Crystallization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Screening for crystallization was performed with DYRK1A in 96-well sitting-drop plates, mixing 200 nl protein solution with 200 nl precipitant solution. Commercially available screens as well as in-house screens were used. An initial hit was found in the JCSG-plus screen (Molecular Dimensions) consisting of 0.2 M sodium thiocyanate, 20% PEG 3350. This condition was further optimized and improved by an additive screen with 96 conditions (Hampton Research), which produced the final crystallization condition: 10-16% PEG 3350, 0.1 M potassium thiocyanate, 0.1 M KCl (or 0.1 M NaCl or 0.1 M LiCl; other salts of alkali halides were also successfully used).
For co-crystallization with the inhibitor PKC412, the kinase DYRK1A was concentrated to 7-10 mg ml À1 in SEC buffer and mixed with inhibitor solution in DMSO to achieve an approximately threefold molar excess of inhibitor. The final concentration of DMSO was $4%. The protein-inhibitor mixture was then mixed in a 1:1 ratio with the crystallization solution [100 mM potassium thiocyanate, 50-100 mM LiCl (or NaCl or KCl), 10-16% PEG 3350] to give a final drop size of 4 ml. Crystallization was performed in 24-well hanging-drop plates. Octahedron-shaped crystals appeared within 5-7 d at room temperature. Crystals were cryoprotected in crystallization solution modified to include 30% ethylene glycol and were flash-cooled in liquid nitrogen.
+ Open protocol
+ Expand
8

Crystallization and X-ray Diffraction of Enzyme

Check if the same lab product or an alternative is used in the 5 most similar protocols
The enzyme was crystallized at 296 K using the sitting-drop vapour-diffusion method in 96-well plates (CrystalQuick, Greiner Bio-One, Germany). Drops were prepared using 1 ml electronic reprint protein solution mixed with 1 ml reservoir solution and were equilibrated against 100 ml precipitant solution. The concentration of the protein was 10 mg ml À1 in 50 mM Tris pH 7.2. Initial crystallization condition were found using the JCSGplus screen (Molecular Dimensions) and were optimized. Diffraction-quality crystals grew within one week to approximate dimensions of 0.2 Â 0.2 Â 0.3 mm from a solution consisting of 8% PEG 8000, 8% ethylene glycol, 100 mM HEPES pH 7.5. The crystals belonged to the primitive tetragonal space group P4 1 , with unit-cell parameters a = 84.09, c = 316.38 A ˚. The asymmetric unit contained two tetramers (V M = 2.8 A ˚3 Da À1 , solvent content 56.1%) related by pseudotranslational symmetry. A native data set extending to a maximum resolution of 1.9 A ˚was collected on the BM30A beamline at ESRF, Grenoble, France using a ADSC Quantum 315r detector and a wavelength of 0.979 A ˚. For data collection a crystal of the enzyme was cooled to 100 K using a solution consisting of 15% PEG 8000, 15% ethylene glycol, 100 mM HEPES pH 7.5 as cryoprotectant. The data were processed with XDS (Kabsch, 2010).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!